2022
DOI: 10.1002/hep4.1912
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models

Abstract: Shear wave elastography (SWE) is an ultrasound-based stiffness quantification technology that is used for noninvasive liver fibrosis assessment. However, despite widescale clinical adoption, SWE is largely unused by preclinical researchers and drug developers for studies of liver disease progression in small animal models due to significant experimental, technical, and reproducibility challenges. Therefore, the aim of this work was to develop a tool designed specifically for assessing liver stiffness and echog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 53 publications
0
6
0
Order By: Relevance
“…Dual MCT1KO in hepatocytes plus hepatic stellate cells showed no change in overall fibrosis, similar to the Chol-MCT1-siRNA results ( Figure 5G and H ). Additionally, liver stiffness was monitored via ultrasound-based shear wave elastography (SWE) in a noninvasive diagnostic mode for liver disease ( Morin et al, 2021 ; Czernuszewicz et al, 2022 ). After 8 weeks of CDHFD, all groups had the same level of increased liver stiffness above what the control mice showed at 4 weeks, however, Hep KO mice exhibited elevated liver stiffness over all other groups at 4 weeks of the diet ( Figure 7F and G ).…”
Section: Resultsmentioning
confidence: 99%
“…Dual MCT1KO in hepatocytes plus hepatic stellate cells showed no change in overall fibrosis, similar to the Chol-MCT1-siRNA results ( Figure 5G and H ). Additionally, liver stiffness was monitored via ultrasound-based shear wave elastography (SWE) in a noninvasive diagnostic mode for liver disease ( Morin et al, 2021 ; Czernuszewicz et al, 2022 ). After 8 weeks of CDHFD, all groups had the same level of increased liver stiffness above what the control mice showed at 4 weeks, however, Hep KO mice exhibited elevated liver stiffness over all other groups at 4 weeks of the diet ( Figure 7F and G ).…”
Section: Resultsmentioning
confidence: 99%
“…Dual MCT1KO in hepatocytes plus hepatic stellate cells showed no change in overall fibrosis, similar to the Chol-MCT1-siRNA results (Figure 5G, 5H). Additionally, liver stiffness was monitored via ultrasound-based shear wave elastography (SWE) in a noninvasive diagnostic mode for liver disease 48,49 . After 8 weeks of CDHFD, all groups had the same level of increased liver stiffness above what the control mice showed at 4 weeks, however, Hep KO mice exhibited elevated liver stiffness over all other groups at 4 weeks of the diet (Figure 7F, 7G).…”
Section: Resultsmentioning
confidence: 99%
“…Dual MCT1KO in hepatocytes plus hepatic stellate cells showed no change in overall fibrosis, similar to the Chol-MCT1-siRNA results (Figure 5G, 5H). Additionally, liver stiffness was monitored via ultrasound-based shear wave elastography (SWE) in a noninvasive diagnostic mode for liver disease 48,49 .…”
Section: Hepatocyte-specific Mct1ko Accelerated Fibrosis While Hepati...mentioning
confidence: 99%
“…In a CCl 4 mouse model, magnetic resonance elastography and atomic force microscopy demonstrated a heterogeneous distribution of liver stiffness at macroscopic and microscopic levels, respectively, with high stiffness being attributed to areas of dense extracellular matrix ( Kostallari et al, 2022 ). In another study, ultrasound measurements of echogenicity and stiffness in the liver were strongly correlated with macrovesicular steatosis and fibrosis, respectively, for mice submitted to a choline-deficient, L-amino acid-defined, high-fat diet to induce NASH features ( Czernuszewicz et al, 2022 ). Also, SWE demonstrated the predisposition of mice with hepatic epithelial cell-specific deletion of leucine-rich repeat-containing G-protein–coupled receptors 4 and 5 (Lgr4/5dLKO) to liver fibrosis.…”
Section: Introductionmentioning
confidence: 99%